The Enterprise Value as of November 2024 (TTM) for Virpax Pharmaceuticals, Inc. (VRPX) is 4.57M

According to Virpax Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 4.57M. This represents a change of 226.24% compared to the average of 2.02K of the last 4 quarters.

Virpax Pharmaceuticals, Inc. (VRPX) Historical Enterprise Value (quarterly & annually)

How has VRPX Enterprise Value performed in the past?

The mean historical Enterprise Value of Virpax Pharmaceuticals, Inc. over the last ten years is 63.11M. The current 4.57M Enterprise Value has changed 623.83% with respect to the historical average. Over the past ten years (40 quarters), VRPX's Enterprise Value was at its highest in in the December 2019 quarter at 324.14M. The Enterprise Value was at its lowest in in the December 2022 quarter at -11709001.84.

Virpax Pharmaceuticals, Inc. (VRPX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Virpax Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Virpax Pharmaceuticals, Inc. (VRPX) Average Enterprise Value

How has VRPX Enterprise Value performed in the past?

The current Enterprise Value of Virpax Pharmaceuticals, Inc. (VRPX) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Virpax Pharmaceuticals, Inc. (VRPX) Enterprise Value vs. Peers

How is VRPX’s Enterprise Value compared to its peers?

Virpax Pharmaceuticals, Inc.’s Enterprise Value is less than Panbela Therapeutics, Inc. (4.75M), greater than Revelation Biosciences, Inc. (-3300245.00), greater than Palisade Bio, Inc. (-4438971.00), less than Virax Biolabs Group Limited (5.36M), greater than Quoin Pharmaceuticals, Ltd. (-162664.00), less than ZIVO Bioscience, Inc. (73.95M), less than RenovoRx, Inc. (21.40M), greater than Pasithea Therapeutics Corp. (-5435245.00), greater than ARCA biopharma, Inc. (1.56M), less than Nutriband Inc. (46.88M), less than Longeveron Inc. (6.86M), less than Blue Water Vaccines, Inc. (8.67M), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kiora Pharmaceuticals, Inc. (4.55M), greater than Biodexa Pharmaceuticals Plc (-2820215.62), less than Praxis Precision Medicines, Inc. (1.22B),

Build a custom stock screener for Virpax Pharmaceuticals, Inc. (VRPX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Virpax Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Virpax Pharmaceuticals, Inc. (VRPX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Virpax Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.